Shi et al. [80] have reported that Wnt5a mRNA silencing in rat chondrocytes might be a therapeutic target in osteoarthritis treatment, as up-regulation of Wnt5a promotes the degradation of type II collagen IL-1β, contributing to the progression of osteoarthritis. The gene discussed is WNT5A; the disease is osteoarthritis.